Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04358770 · ClinicalTrials.gov registry record · Phase 1
Bio-equivalence Vasoconstriction Activity Study for Topically Applied Clocortolone Pivalate 0.1% Cream
A Phase 1 study, sponsored by Sun Pharmaceutical Industries.
- Completed
- Registry status
- Phase 1
- Development phase
- 124
- Enrollment target
NCT04358770 is a Phase 1 study that has completed, run by Sun Pharmaceutical Industries. The registered enrollment target is 124 participants.
The verdict
NCT04358770, a Phase 1 study, has completed, sponsored by Sun Pharmaceutical Industries.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 124 participants
- Enrollment target
Study Summary
To compare pharmacodynamic vasoconstriction response profile of Clocortolone Pivalate 0.1% Cream and Cloderm® (Clocortolone Pivalate) 0.1% Cream in normal skin of healthy male and female adults
Interventions
- DRUG Clocortolone Pivalate
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 124 participants |
| Start Date | 2018-03-02 |
| Est. Completion | 2018-05-11 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04358770
The ClinicalTrials.gov registry entry for NCT04358770 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 124 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Sun Pharmaceutical Industries, which has 48 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Clocortolone Pivalate is the first listed.
NCT04358770 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04358770 about?
NCT04358770 is a clinical study titled "Bio-equivalence Vasoconstriction Activity Study for Topically Applied Clocortolone Pivalate 0.1% Cream". To compare pharmacodynamic vasoconstriction response profile of Clocortolone Pivalate 0.1% Cream and Cloderm® (Clocortolone Pivalate) 0.1% Cream in normal skin of healthy male and female adults
What is the current status of trial NCT04358770?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 124 participants. The study started on 2018-03-02. Estimated completion is 2018-05-11.
What interventions are being tested in trial NCT04358770?
The interventions under investigation include: Clocortolone Pivalate (DRUG).
Who is sponsoring clinical trial NCT04358770?
This trial is sponsored by Sun Pharmaceutical Industries, which has 48 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.